These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22051859)

  • 1. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
    Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
    Jao J; Bonner LB; Dobinda K; Powis KM; Sun S; Legbedze J; Mmasa KN; Makhema J; Mmalane M; Kgole S; Masasa G; Moyo S; Gerschenson M; Mohammed T; Abrams EJ; Kurland IJ; Geffner ME
    Clin Infect Dis; 2024 Sep; 79(3):727-733. PubMed ID: 38531012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
    Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
    Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
    Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
    AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.
    Ekouevi DK; Touré R; Becquet R; Viho I; Sakarovitch C; Rouet F; Towne-Gold B; Fassinou P; Leroy V; Blanche S; Dabis F;
    Pediatrics; 2006 Oct; 118(4):e1071-7. PubMed ID: 16950945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for Speech and Language Impairments in Preschool Age HIV-exposed Uninfected Children With In Utero Combination Antiretroviral Exposure.
    Rice ML; Russell JS; Frederick T; Purswani M; Williams PL; Siberry GK; Redmond SM; Hoffman HJ; Yao TJ;
    Pediatr Infect Dis J; 2018 Jul; 37(7):678-685. PubMed ID: 29278615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.
    Nozyce ML; Huo Y; Williams PL; Kapetanovic S; Hazra R; Nichols S; Hunter S; Smith R; Seage GR; Sirois PA;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1128-33. PubMed ID: 25361407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
    Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
    Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
    Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
    AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
    Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of health programmes to prevent vertical transmission of HIV. Advances, emerging health challenges and research priorities for children exposed to or living with HIV: Perspectives from South Africa.
    Goga A; Slogrove A; Wedderburn CJ; Feucht U; Wessels J; Ramokolo V; Bhana A; Du Plessis N; Green RJ; Pillay Y; Sherman G
    S Afr Med J; 2019 Dec; 109(11b):77-82. PubMed ID: 32252873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
    AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.